Skip to main content

Advertisement

Table 2 Characteristics of cancer chemotherapy patients receiving alkylant agents

From: Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy

Gender   
  Group 1 (mucositis) n = 241 n (%) Group 2 (no mucositis) n = 96 n (%)
Male 146 (60.5) 67 (69.7)
Female 95 (39.5) 29 (30.3)
χ2 Mantel-Haenszel = 2.50 p = 0.11
Diagnosis   
  Group 1 (mucositis) n = 241 n (%) Group 2 (no mucositis) n = 96 n (%)
Cerebral tumors 70 (30.7) 27 (28.1)
Germinal tumors 78 (32.4) 22 (22.9)
Sarcoma 68 (28.2) 36 (37.5)
Hodgkin 9 (3.7) 11 (11.5)
Other 12 (5.0) - (--)
χ2 = 13.46 p < 0.01
Chemotherapy Regimens   
  Group 1 (mucositis) n = 241 n (%) Group 2 (no mucositis) n = 96 n (%)
Melphalan® 24 (9.9) 20 (20.8)
Busulfan® 153 (63.5) 34 (35.4)
Other 64 (26.6) 42 (43.8)
χ2 = 22.42 p < 0.001